Original news and analysis on international IP policy
As part of a larger report on the G20 top global economies, the World Trade Organization has provided a discussion of policy developments in trade and intellectual property. This includes a look at international policy actions, recent agreements, and national legislation and trends.
A new analysis released this week by the United States Chamber of Commerce Global Intellectual Property Center (GIPC) shows that some 86 percent of all physical counterfeiting comes from China and Hong Kong. Companies locating manufacturing there may not be surprised to find counterfeit versions of their products on the market, and seizures are a small fraction of the goods getting into the global trade stream, the report says.
United States Trade Representative Michael Froman today said biologics remain one of the biggest unresolved issues in getting the Trans-Pacific Partnership passed in the US Congress. He called biologics an intellectual property rights issue and said the administration is working with Congress and industry to resolve concerns without reopening the trade deal completed last autumn.
The 28 European Union governments today gave final approval to a first-ever plan to analyse medicines competition in Europe, with reference to drug prices, generics and biosimilars, and intellectual property rights. The final version was watered down after what sources said was heavy industry lobbying, compared to a leaked version published in Intellectual Property Watch two weeks ago, but still retains some strong provisions regarding pricing and competition.
A new response plan for a strategic response to the Zika virus has been announced by the World Health Organization and the Pan American Health Organization.
Last year, amid protests from some World Intellectual Property Organization members, a new treaty was adopted to protect geographical indications, broadening an existing treaty. One of the objections of some was that the existing treaty was not financially sustainable, and was piggybacking on other WIPO income-generating treaties. Last week, members of the treaty went over possible solutions to bring money into the system. Italy and France, the biggest beneficiaries, committed actual funds.
The 28 European Union member governments have concluded next steps for addressing antimicrobial resistance, with a strong emphasis on reducing use of antibiotics in animals, but also including a call for new business models.
Doors to a global medical harmonisation organisation opened to the generic and biosimilar industry, which described it as an historical moment for them. The industry will now be able to sit on the assembly of the international body that joins regulators with the pharmaceutical industry.
The quest of balance between encouraging medical innovation and the imperative of broad access to medicines has so far been elusive. Two Harvard University programmes jointly organised a workshop this week with the aim of encouraging a conversation between global health actors and see if some "outside the box" thinking is possible.
A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products. The guidelines, written by a well-known advocate of access to medicines, aim at advising patent examiners in assessing the patentability requirements of applications relating to pharmaceutical products and processes.
Movement has been happening in international organisations in recent weeks, particularly in United Nations agencies, as new executive directors were nominated, and department directorships changed hands. The private sector and non-governmental organisations also saw a number of position switches and nominations, in particular in the health sector. Law offices kept pace with the usual chair revolving.
Dans le sillage du Groupe de Haut Niveau des Nations Unies sur l’accès aux médicaments, cette série d’articles sponsorisés convie des experts à donner leur point de vue sur les politiques les mieux à même de favoriser l’élaboration de solutions…